Categories: News

Update on full-year outlook for 2022

Company announcement no. 26 – 22
6 December 2022

Update on full-year outlook for 2022

Based on the financial performance during the first ten months of 2022, preliminary financial results for November 2022, and financial expectations for December 2022, NTG Nordic Transport Group A/S (“NTG”) adjusts its full-year outlook for 2022 as follows:

  • Revenue around DKK 10,200 million (previously DKK 9,700 – 10,200 million)
  • Adj. EBIT around DKK 750 million (previously DKK 700 – 750 million)

The full-year outlook for 2022 is adjusted based on indications of a stabilisation in certain markets during November and December of the year.

Additional information

For additional information, please contact:

Investor relations:
Christian D. Jakobsen, Group CFO                                    
+45 42 12 80 99
ir@ntg.com
Press:
Mathias Jensen-Vinstrup, Executive Vice President
+45 42 12 80 90
press@ntg.com

Attachment

Staff

Recent Posts

GE HealthCare Announces Cash Dividend for First Quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a…

34 mins ago

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases…

35 mins ago

Smartsheet Names Katie Rooney to Board of Directors

Experienced global CFO adds depth in financial strategy and operating excellence to Smartsheet boardBELLEVUE, Wash.--(BUSINESS…

36 mins ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation

The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic…

37 mins ago

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash. (March…

2 hours ago